Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_assertion type Assertion NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_head.
- NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_assertion description "[Anti-Fas monoclonal antibody (mAb) was added to RA synoviocytes after treatment with tumor necrosis factor alpha (TNFalpha) or basic fibroblast growth factor (bFGF) for 5 days.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_provenance.
- NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_assertion evidence source_evidence_literature NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_provenance.
- NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_assertion SIO_000772 10817565 NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_provenance.
- NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_assertion wasDerivedFrom befree-20150227 NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_provenance.
- NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_assertion wasGeneratedBy ECO_0000203 NP398305.RAtvrbnpw22qjFx7dG6qyimd7ceo-HZs7q3aNEGkFx-A4130_provenance.